Microangiopathic hemolytic anemia causes: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
MydahSajid (talk | contribs) |
||
| (4 intermediate revisions by 2 users not shown) | |||
| Line 2: | Line 2: | ||
{{Microangiopathic hemolytic anemia}} | {{Microangiopathic hemolytic anemia}} | ||
{{CMG}} | |||
{{CMG}} {{AE}} {{MSJ}} | |||
==Overview== | ==Overview== | ||
[[Microangiopathic hemolytic anemia]] is a clinical manifestation of a large number of [[disease]]s. The [[gentic]] [[mutation]]s make some patients prone to [[microangiopathic hemolytic anemia]]. | |||
==Causes== | ==Causes== | ||
The most important causes are: | The most important causes are<ref name="pmid28447417">{{cite journal| author=Kottke-Marchant K| title=Diagnostic approach to microangiopathic hemolytic disorders. | journal=Int J Lab Hematol | year= 2017 | volume= 39 Suppl 1 | issue= | pages= 69-75 | pmid=28447417 | doi=10.1111/ijlh.12671 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28447417 }} </ref>: | ||
* [[Aortic Stenosis]] (most common cause of MAHA) | * [[Aortic Stenosis]] (most common cause of MAHA) | ||
* [[Thrombotic thrombocytopenic purpura]] (TTP) | * [[Thrombotic thrombocytopenic purpura]] (TTP) | ||
* [[Hemolytic uremic syndrome]] (HUS) | * [[Hemolytic uremic syndrome]] (HUS) | ||
* [[Disseminated intravascular coagulation]] (DIC) | * [[Disseminated intravascular coagulation]] (DIC) | ||
* Drug Side Effect- [[Cyclosporine]] | |||
* [[HELLP syndrome]] and [[eclampsia]] | * [[HELLP syndrome]] and [[eclampsia]] | ||
* [[Heparin-induced thrombocytopenia]] (HIT) | * [[Heparin-induced thrombocytopenia]] (HIT) | ||
Latest revision as of 20:54, 31 January 2021
|
Microangiopathic hemolytic anemia Microchapters |
|
Differentiating Microangiopathic hemolytic anemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Microangiopathic hemolytic anemia causes On the Web |
|
American Roentgen Ray Society Images of Microangiopathic hemolytic anemia causes |
|
Directions to Hospitals Treating Microangiopathic hemolytic anemia |
|
Risk calculators and risk factors for Microangiopathic hemolytic anemia causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mydah Sajid, MD[2]
Overview
Microangiopathic hemolytic anemia is a clinical manifestation of a large number of diseases. The gentic mutations make some patients prone to microangiopathic hemolytic anemia.
Causes
The most important causes are[1]:
- Aortic Stenosis (most common cause of MAHA)
- Thrombotic thrombocytopenic purpura (TTP)
- Hemolytic uremic syndrome (HUS)
- Disseminated intravascular coagulation (DIC)
- Drug Side Effect- Cyclosporine
- HELLP syndrome and eclampsia
- Heparin-induced thrombocytopenia (HIT)
- Severe glomerulonephritis
- Several other rare causes
References
- ↑ Kottke-Marchant K (2017). "Diagnostic approach to microangiopathic hemolytic disorders". Int J Lab Hematol. 39 Suppl 1: 69–75. doi:10.1111/ijlh.12671. PMID 28447417.